Gabapentin prophylaxis of clozapine-induced seizures.
Usiskin
S I
SI
Nicolson
R
R
Lenane
M
M
Rapoport
J L
JL
D000085:Acetates / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000588:Amines; D000927:Anticonvulsants / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D004334:Drug Administration Schedule; D004827:Epilepsy / Q000139:chemically induced* / Q000517:prevention & control*; D000077206:Gabapentin; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy; D055502:Secondary Prevention; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D014150:Antipsychotic Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D003024:Clozapine